Ageing with HIV in South Africa

We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients ag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2011-08, Vol.25 (13), p.1665-1667
Hauptverfasser: HONTELEZ, Jan A. C, LURIE, Mark N, NEWELL, Marie-Louise, BAKKER, Roel, TANSER, Frank, BARNIGHAUSEN, Till, BALTUSSEN, Rob, DE VLAS, Sake J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1667
container_issue 13
container_start_page 1665
container_title AIDS (London)
container_volume 25
creator HONTELEZ, Jan A. C
LURIE, Mark N
NEWELL, Marie-Louise
BAKKER, Roel
TANSER, Frank
BARNIGHAUSEN, Till
BALTUSSEN, Rob
DE VLAS, Sake J
description We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.
doi_str_mv 10.1097/QAD.0b013e32834982ea
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3886337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>890679787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</originalsourceid><addsrcrecordid>eNpdkdtLwzAUxoMobk7_A9G9iE_VkybN5UUo87LBQMTLa0jTZIt07Wxaxf_ejs15gRMOh_zO94UvCB1juMAg-eVDen0BGWBiSSwIlSK2egf1MeUkShKOd1EfYiYjSTj00EEIrwCQgBD7qBdjJjAkrI9O05n15Wz44Zv5cDx5Gfpy-Fi13ZC62ht9iPacLoI92vQBer69eRqNo-n93WSUTiNDCW8iB1aInMjMCQbAOhdKDI716kgqJBPSJXkm85zxXEjZFTUOgEsKxApHBuhqrbtss4XNjS2bWhdqWfuFrj9Vpb36e1P6uZpV74oIwQjhncD5RqCu3lobGrXwwdii0KWt2qCEBMYlFyuSrklTVyHU1m1dMKhVtKqLVv2Ptls7-f3C7dJ3lh1wtgF0MLpwtS6NDz8c7X6GJZh8AXW1gH0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>890679787</pqid></control><display><type>article</type><title>Ageing with HIV in South Africa</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</creator><creatorcontrib>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</creatorcontrib><description>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32834982ea</identifier><identifier>PMID: 21681056</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Anti-HIV Agents - therapeutic use ; Biological and medical sciences ; Delivery of Health Care - trends ; Female ; Forecasting ; HIV Infections - epidemiology ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Models, Theoretical ; Population Dynamics ; Prevalence ; Risk Factors ; Risk-Taking ; Rural Health - trends ; Rural Population ; South Africa - epidemiology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>AIDS (London), 2011-08, Vol.25 (13), p.1665-1667</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</citedby><cites>FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24473651$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21681056$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HONTELEZ, Jan A. C</creatorcontrib><creatorcontrib>LURIE, Mark N</creatorcontrib><creatorcontrib>NEWELL, Marie-Louise</creatorcontrib><creatorcontrib>BAKKER, Roel</creatorcontrib><creatorcontrib>TANSER, Frank</creatorcontrib><creatorcontrib>BARNIGHAUSEN, Till</creatorcontrib><creatorcontrib>BALTUSSEN, Rob</creatorcontrib><creatorcontrib>DE VLAS, Sake J</creatorcontrib><title>Ageing with HIV in South Africa</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Delivery of Health Care - trends</subject><subject>Female</subject><subject>Forecasting</subject><subject>HIV Infections - epidemiology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Theoretical</subject><subject>Population Dynamics</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Risk-Taking</subject><subject>Rural Health - trends</subject><subject>Rural Population</subject><subject>South Africa - epidemiology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkdtLwzAUxoMobk7_A9G9iE_VkybN5UUo87LBQMTLa0jTZIt07Wxaxf_ejs15gRMOh_zO94UvCB1juMAg-eVDen0BGWBiSSwIlSK2egf1MeUkShKOd1EfYiYjSTj00EEIrwCQgBD7qBdjJjAkrI9O05n15Wz44Zv5cDx5Gfpy-Fi13ZC62ht9iPacLoI92vQBer69eRqNo-n93WSUTiNDCW8iB1aInMjMCQbAOhdKDI716kgqJBPSJXkm85zxXEjZFTUOgEsKxApHBuhqrbtss4XNjS2bWhdqWfuFrj9Vpb36e1P6uZpV74oIwQjhncD5RqCu3lobGrXwwdii0KWt2qCEBMYlFyuSrklTVyHU1m1dMKhVtKqLVv2Ptls7-f3C7dJ3lh1wtgF0MLpwtS6NDz8c7X6GJZh8AXW1gH0</recordid><startdate>20110824</startdate><enddate>20110824</enddate><creator>HONTELEZ, Jan A. C</creator><creator>LURIE, Mark N</creator><creator>NEWELL, Marie-Louise</creator><creator>BAKKER, Roel</creator><creator>TANSER, Frank</creator><creator>BARNIGHAUSEN, Till</creator><creator>BALTUSSEN, Rob</creator><creator>DE VLAS, Sake J</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110824</creationdate><title>Ageing with HIV in South Africa</title><author>HONTELEZ, Jan A. C ; LURIE, Mark N ; NEWELL, Marie-Louise ; BAKKER, Roel ; TANSER, Frank ; BARNIGHAUSEN, Till ; BALTUSSEN, Rob ; DE VLAS, Sake J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-f0e88d39bf8600608843c12ac12a9489689f5db9dd67d8998994cf0079403e8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Delivery of Health Care - trends</topic><topic>Female</topic><topic>Forecasting</topic><topic>HIV Infections - epidemiology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Theoretical</topic><topic>Population Dynamics</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Risk-Taking</topic><topic>Rural Health - trends</topic><topic>Rural Population</topic><topic>South Africa - epidemiology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HONTELEZ, Jan A. C</creatorcontrib><creatorcontrib>LURIE, Mark N</creatorcontrib><creatorcontrib>NEWELL, Marie-Louise</creatorcontrib><creatorcontrib>BAKKER, Roel</creatorcontrib><creatorcontrib>TANSER, Frank</creatorcontrib><creatorcontrib>BARNIGHAUSEN, Till</creatorcontrib><creatorcontrib>BALTUSSEN, Rob</creatorcontrib><creatorcontrib>DE VLAS, Sake J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HONTELEZ, Jan A. C</au><au>LURIE, Mark N</au><au>NEWELL, Marie-Louise</au><au>BAKKER, Roel</au><au>TANSER, Frank</au><au>BARNIGHAUSEN, Till</au><au>BALTUSSEN, Rob</au><au>DE VLAS, Sake J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ageing with HIV in South Africa</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2011-08-24</date><risdate>2011</risdate><volume>25</volume><issue>13</issue><spage>1665</spage><epage>1667</epage><pages>1665-1667</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>We used an established microsimulation model, quantified to a rural South African setting with a well developed antiretroviral treatment programme, to predict the impact of antiretroviral therapy on the HIV epidemic in the population aged over 50 years. We show that the HIV prevalence in patients aged over 50 years will nearly double in the next 30 years, whereas the fraction of HIV-infected patients aged over 50 years will triple in the same period. This ageing epidemic has important consequences for the South African healthcare system, as older HIV patients require specialized care.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>21681056</pmid><doi>10.1097/QAD.0b013e32834982ea</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 2011-08, Vol.25 (13), p.1665-1667
issn 0269-9370
1473-5571
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3886337
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Anti-HIV Agents - therapeutic use
Biological and medical sciences
Delivery of Health Care - trends
Female
Forecasting
HIV Infections - epidemiology
Human viral diseases
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infectious diseases
Male
Medical sciences
Middle Aged
Models, Theoretical
Population Dynamics
Prevalence
Risk Factors
Risk-Taking
Rural Health - trends
Rural Population
South Africa - epidemiology
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Ageing with HIV in South Africa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A37%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ageing%20with%20HIV%20in%20South%20Africa&rft.jtitle=AIDS%20(London)&rft.au=HONTELEZ,%20Jan%20A.%20C&rft.date=2011-08-24&rft.volume=25&rft.issue=13&rft.spage=1665&rft.epage=1667&rft.pages=1665-1667&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32834982ea&rft_dat=%3Cproquest_pubme%3E890679787%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=890679787&rft_id=info:pmid/21681056&rfr_iscdi=true